How I Treat Higher-Risk MDS
Myelodysplastic syndromes/neoplasms (MDS) are a widely heterogenous group of myeloid malignancies characterized by morphologic dysplasia, a defective hemat
Related Articles
Advancing Drug Development in Myelodysplastic Syndromes
Myelodysplastic syndromes/neoplasms (MDS) are heterogeneous stem cell malignancies characterized by poor prognosis and no curative therapies outside of all
Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from…
The Price Is NOT Right: Payers’ Roles in Addressing Financial Toxicity | JCO Oncology Practice
From an economic perspective, one of the fundamental features of a well-designed insurance plan is financial protection against catastrophic loss. 1 Yet, while the United…
Support Dr. Seewaldt rebuild after home loss in Cali fire, organized by katherine tossas
Support Dr. Victoria Seewaldt: Help Rebuild After the Califor… katherine tossas needs your support for Support Dr. Seewaldt rebuild after home loss in Cali fire
Lower-intensity therapy for good-risk B-ALL
In this issue of Blood, Purvis et al1 have demonstrated that most children with B-lineage acute lymphoblastic leukemia (B-ALL) within the good-risk categor
Some Assembly Required
The IKEA effect and my new carOnce upon a time, when you bought a car, all you needed to know was where the gear shift…
Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial
Background: COVID-19 convalescent plasma (CCP) is a treatment option for COVID-19. This study investigated the safety and efficacy of early, very high-titre CCP
Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from…
Survival in Patients With Hematologic Cancers and COVID-19
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.